chikungunya virus infection

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)

Not yet recruiting
  • Chikungunya Virus Infection
  • VLA1553 full dose
  • +2 more
  • (no location specified)
Oct 24, 2023

Chikungunya Virus Infection Trial (VLA1553)

Not yet recruiting
  • Chikungunya Virus Infection
  • VLA1553
  • (no location specified)
Aug 31, 2023

Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)

Not yet recruiting
  • Chikungunya Virus Infection
  • PXVX0317 vaccine booster
  • Placebo booster
  • (no location specified)
Aug 18, 2023

Chikungunya Virus Infection Trial in San Juan (V184, Placebo)

Completed
  • Chikungunya Virus Infection
  • V184
  • Placebo
  • San Juan, Puerto Rico
    San Juan Hospital, Research Unit
Sep 6, 2022

Chikungunya Virus Infection Trial in Lenexa, Durham (Placebo, SAR440894)

Recruiting
  • Chikungunya Virus Infection
  • Placebo
  • SAR440894
  • Lenexa, Kansas
  • +1 more
Aug 18, 2022

Chikungunya Virus Infection Trial in United States (VLA1553, Placebo)

Completed
  • Chikungunya Virus Infection
  • VLA1553
  • Placebo
  • Chandler, Arizona
  • +43 more
Jul 25, 2022

Chikungunya Virus Infection Trial in United States (Biological Vaccine VLA1553)

Completed
  • Chikungunya Virus Infection
  • Biological Vaccine VLA1553
  • Coral Gables, Florida
  • +11 more
Jan 31, 2022

Chikungunya Virus Infection Trial in Lenexa, Kansas City, West Jordan (CHIKV VLP/unadjuvanted, CHIKV VLP/adjuvanted, Placebo)

Completed
  • Chikungunya Virus Infection
  • CHIKV VLP/unadjuvanted
  • +2 more
  • Lenexa, Kansas
  • +2 more
Oct 12, 2021

Chikungunya Virus Infection Trial in Austria, Germany (MV-CHIK low dose, MV-CHIK high dose, Priorix®)

Completed
  • Chikungunya Virus Infection
  • MV-CHIK low dose
  • +3 more
  • Graz, Austria
  • +3 more
Oct 15, 2021

Chikungunya Virus Infection Trial in United States (VLA1553)

Enrolling by invitation
  • Chikungunya Virus Infection
  • VLA1553
  • Phoenix, Arizona
  • +10 more
Oct 21, 2021

Chikungunya Virus Infection Trial in Saint-Pierre (OPHTHALMOLOGICAL ASSESSMENT, NEUROPSYCHOLOGICAL ASSESSMENT)

Recruiting
  • Chikungunya Virus Infection
  • OPHTHALMOLOGICAL ASSESSMENT
  • NEUROPSYCHOLOGICAL ASSESSMENT
  • Saint-Pierre, Réunion
    CHU de La Réunion
Jun 2, 2021

Dengue Fever Trial in Belo Horizonte (Brazilian National Dengue Control Program, Wolbachia-infected Aedes aegypti)

Recruiting
  • Chikungunya Virus Infection
  • +3 more
  • Brazilian National Dengue Control Program
  • Wolbachia-infected Aedes aegypti
  • Belo Horizonte, Minas Gerais, Brazil
    Universidade Federal de Minas Gerais, Instituto de Ciencias Biol
May 27, 2021

Chikungunya Virus Infection Trial in Atlanta, Iowa City, Houston (Placebo, VRC-CHKVLP059-00-VP)

Completed
  • Chikungunya Virus Infection
  • Placebo
  • VRC-CHKVLP059-00-VP
  • Atlanta, Georgia
  • +2 more
Nov 25, 2020

Chikungunya Virus Infection Trial in Worldwide (VRC-CHKVLP059-00-VP, VRC-PBSPLA043-00-VP)

Completed
  • Chikungunya Virus Infection
  • VRC-CHKVLP059-00-VP
  • VRC-PBSPLA043-00-VP
  • Santo Domingo, Dominican Republic
  • +5 more
Oct 20, 2020

Chikungunya Virus Infection Trial in Pointe-à-Pitre (Wait-list group, Yoga group)

Terminated
  • Chikungunya Virus Infection
  • Wait-list group
  • Yoga group
  • Pointe-à-Pitre, Guadeloupe
    Mouffias' Medical Center in Guadeloupe.
Jul 1, 2020

Seroprevalence of Chikungunya at End of First Chikungunya

Completed
  • HIV Infections
  • Chikungunya Virus Infection
  • Biological sample collection
  • Pointe-à-Pitre, Guadeloupe, France
  • +1 more
Jul 25, 2016

Viral Vaccines, Chikungunya Fever, Chikungunya Virus Infection Trial run by the NIAID (VRC-CHKVLP059-00-VP)

Completed
  • Viral Vaccines
  • +2 more
  • VRC-CHKVLP059-00-VP
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 9, 2016

Chikungunya Virus Infection Trial in Basse-Terre, Cayenne, Fort-de-France (anti-CHIKV hyperimmune immunoglobulins)

Unknown status
  • Chikungunya Virus Infection
  • anti-CHIKV hyperimmune immunoglobulins
  • Basse-Terre, Guadeloupe, France
  • +2 more
Oct 31, 2014